V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270017978 | 270019133 | 0 | 79.8 | Curative (C) | 2015-04-18 | 2015-07-29 | Cisplatin + Radiotherapy | N | Y | 270014526 | CISPLATIN + RT |
| 270017979 | 270008831 | 1.74 | 60.1 | Palliative (P) | 2014-09-16 | 2014-10-17 | HD EuroNet-PHL-C1 OEPA | null | null | 270014528 | OEPA |
| 270017980 | 270008834 | 1.7 | 58.3 | Palliative (P) | 2016-10-02 | 2016-10-06 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 270014529 | CETUXIMAB + IRINOTECAN + MDG |
| 270017981 | 270008837 | 1.68 | 82.9 | Curative (C) | 2015-05-31 | 2015-06-05 | BEAM | 02 | null | 270014542 | BEAM |
| 270017982 | 270008844 | 1.68 | 103.7 | Curative (C) | 2015-09-09 | 2015-09-13 | ESHAP | N | N | 270014553 | ESHAP |
| 270017983 | 270008849 | 1.58 | 86 | Radical (R) | 2017-06-21 | 2017-06-28 | CISPLATIN + RT | 2 | N | 270014555 | CISPLATIN + RT |
| 270017984 | 270018265 | null | 17 | Curative (C) | 2014-09-27 | 2014-10-19 | ESHAP | 2 | N | 270014558 | ESHAP |
| 270017985 | 270008854 | 1.65 | 116.3 | Palliative (P) | 2016-12-10 | 2016-12-17 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014563 | CETUXIMAB + IRINOTECAN + MDG |
| 270017986 | 270008856 | 1.48 | 20.8 | Curative (C) | 2018-01-04 | 2018-01-04 | OEPA | N | N | 270014564 | OEPA |
| 270017987 | 270018268 | 1.84 | 51.6 | Adjuvant (A) | 2017-07-31 | 2017-08-03 | HD EuroNet-PHL-C1 OEPA | N | N | 270014568 | OEPA |
| 270017988 | 270008867 | 1.76 | 69.1 | null | 2016-04-12 | 2016-04-17 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014581 | CISPLATIN + RT |
| 270017989 | 270016769 | 1.72 | 73.4 | Curative (C) | 2016-05-27 | 2016-10-19 | BEAM | 2 | Y | 270014594 | BEAM |
| 270017990 | 270008881 | 1.74 | null | Curative (C) | 2017-08-02 | 2017-09-05 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270014607 | CETUXIMAB + IRINOTECAN + MDG |
| 270017991 | 270008882 | null | 67 | Palliative (P) | null | 2016-08-20 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | Y | 270014609 | CETUXIMAB + IRINOTECAN + MDG |
| 270017992 | 270008885 | 1.62 | 60 | Curative (C) | 2014-05-17 | 2014-05-17 | LEAM | N | N | 270014610 | LEAM |
| 270017993 | 270014181 | 1.56 | 53.8 | Not known (9) | 2015-04-22 | 2016-01-13 | Rituximab | 02 | N | 270014620 | RITUXIMAB |
| 270017994 | 270019139 | 1.53 | 65 | Curative (C) | 2015-04-13 | 2015-04-14 | LEAM | N | Y | 270014625 | LEAM |
| 270017995 | 270008896 | 1.7 | 64 | Curative (C) | 2017-09-23 | 2017-10-05 | ESHAP | N | N | 270014627 | ESHAP |
| 270017996 | 270008904 | 1.67 | 61.6 | Curative (C) | 2017-01-02 | 2017-01-05 | LEAM | N | N | 270014641 | LEAM |
| 270017997 | 270008906 | 1.87 | 63.5 | Palliative (P) | 2014-03-22 | 2016-10-28 | Cetuximab + FLUOROURACIL + IRINOTECAN | null | null | 270014646 | CETUXIMAB + IRINOTECAN + MDG |
| 270017998 | 270019630 | 1.69 | 84.45 | null | 2018-08-14 | 2018-08-28 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270014648 | CETUXIMAB + IRINOTECAN + MDG |
| 270017999 | 270016780 | null | 44.7 | Curative (C) | null | 2015-12-26 | Rituximab | 02 | null | 270014658 | RITUXIMAB |
| 270018000 | 270008911 | 0 | 95 | Curative (C) | 2016-10-19 | 2016-10-27 | ESHAP | N | null | 270014659 | ESHAP |
| 270018001 | 270014193 | 1.79 | 79 | Palliative (P) | 2013-09-23 | 2013-10-23 | OEPA | N | N | 270014660 | OEPA |
| 270018002 | 270008915 | null | 74.9 | Adjuvant (A) | 2017-07-24 | 2018-02-11 | Rituximab | 2 | Y | 270014661 | RITUXIMAB |
| 270018003 | 270008918 | 1.78 | null | Curative (C) | 2018-04-10 | 2018-04-24 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | N | N | 270014662 | CETUXIMAB + IRINOTECAN + MDG |
| 270018004 | 270008921 | null | 54.6 | null | 2013-11-03 | 2013-12-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014666 | CETUXIMAB + IRINOTECAN + MDG |
| 270018005 | 270016783 | 1.95 | 99.8 | Curative (C) | 2014-03-03 | 2014-04-20 | CISPLATIN + RT | N | N | 270014677 | CISPLATIN + RT |
| 270018006 | 270008925 | null | 59 | Curative (C) | 2015-11-06 | 2016-11-15 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270014681 | CETUXIMAB + IRINOTECAN + MDG |
| 270018007 | 270014199 | 1.78 | 84.45 | Curative (C) | 2014-05-19 | 2014-07-23 | Cisplatin + Radiotherapy | 02 | null | 270014681 | CISPLATIN + RT |
| 270018008 | 270016785 | 1.86 | 65.9 | Curative (C) | 2016-01-28 | 2016-03-10 | Rituximab | N | N | 270014684 | RITUXIMAB |
| 270018009 | 270014202 | 1.7 | null | null | 2016-04-16 | 2016-04-19 | LEAM | 02 | Y | 270014699 | LEAM |
| 270018010 | 270008932 | 1.8 | 79.8 | Curative (C) | 2014-10-09 | 2014-10-09 | CETUXIMAB + IRINOTECAN + MDG | N | null | 270014705 | CETUXIMAB + IRINOTECAN + MDG |
| 270018011 | 270008936 | 1.24 | 64.4 | Curative (C) | 2014-06-27 | 2014-06-27 | BEAM | N | N | 270014707 | BEAM |
| 270018012 | 270008941 | null | 81.4 | Disease modification (D) | null | 2017-07-24 | Rituximab (Maintenance) | N | N | 270014715 | RITUXIMAB |
| 270018014 | 270008948 | 1.88 | 65.2 | Adjuvant (A) | 2014-02-05 | 2014-02-06 | LEAM | N | N | 270014736 | LEAM |
| 270018015 | 270008949 | 0 | 0 | Curative (C) | 2015-04-09 | 2015-04-09 | ESHAP | 02 | N | 270014745 | ESHAP |
| 270018016 | 270008955 | 1.83 | 40.3 | Palliative (P) | 2015-04-05 | 2015-04-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014758 | CETUXIMAB + IRINOTECAN + MDG |
| 270018017 | 270014211 | 0.98 | 95 | Curative (C) | 2016-04-06 | 2016-04-18 | Rituximab | N | N | 270014762 | RITUXIMAB |
| 270018018 | 270014211 | 1.75 | null | Curative (C) | 2015-12-10 | 2015-12-19 | BEAM | N | N | 270014762 | BEAM |
| 270018019 | 270019913 | null | 95.1 | Palliative (P) | 2018-05-05 | 2018-05-05 | OEPA | N | N | 270014777 | OEPA |
| 270018020 | 270020226 | null | 60.6 | Curative (C) | 2017-02-26 | 2017-02-28 | LEAM | 2 | N | 270014779 | LEAM |
| 270018021 | 270014214 | 1.46 | null | Curative (C) | 2015-02-16 | 2015-02-19 | OEPA | 02 | N | 270014784 | OEPA |
| 270018022 | 270008972 | 1.4 | 80.4 | Curative (C) | 2019-01-09 | 2019-01-15 | ESHAP | 2 | N | 270014787 | ESHAP |
| 270018023 | 270016795 | 1.69 | 79.8 | Curative (C) | 2014-04-08 | 2014-04-09 | BEAM | N | N | 270014790 | BEAM |
| 270018024 | 270008978 | 1.55 | 69.7 | Palliative (P) | null | 2016-06-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270014792 | CETUXIMAB + IRINOTECAN + MDG |
| 270018025 | 270008990 | 1.8 | 84 | null | 2017-08-02 | 2017-08-27 | HD EuroNet-PHL-C1 OEPA | null | null | 270014823 | OEPA |
| 270018026 | 270014222 | 1.57 | 56 | Curative (C) | 2016-11-29 | 2016-11-29 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270014829 | CETUXIMAB + IRINOTECAN + MDG |
| 270018027 | 270008996 | 1.77 | 109.3 | Curative (C) | 2017-09-21 | 2017-09-21 | ESHAP | 02 | N | 270014831 | ESHAP |
| 270018028 | 270009001 | 1.68 | 84.9 | Curative (C) | 2018-07-14 | 2018-07-14 | OEPA | N | N | 270014834 | OEPA |